Skip to Main Navigation

ESV:Addressing Non-Communicable Diseases

Development Objective

The objective of the Project is to support the Government of El Salvador in piloting an integrated health care service delivery model to improve the prevention, early detection, and treatment of cervical cancer as well as the prevention of NCD risk factors in selected regions of El Salvador.

Key Details

Project Details

  • P164356

  • Closed

  • Amparo Gordillo-Tobar , Roberto Iunes

  • Republic of El Salvador

  • El Salvador

  • December 5, 2017

  • (as of board presentation)

    September 13, 2018

  • December 19, 2018

  • US$ 1.80 million

  • N/A

  • April 25, 2024

  • March 31, 2023

  • Yes

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Pharmaceutical Governance Fund 1.80

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment N/A
IBRD + IDA Commitment N/A
Lending Instrument
Grant Amount 1.80
Total Project Cost** 1.80

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of February 28, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Satisfactory 2022-07-29
Overall Implementation Progress (IP) Satisfactory 2022-07-29
Overall Moderable 2022-07-29

COMPLETION RATINGS

INDICATORIMPLEMENTATION COMPLETION & RESULTS REPORT:
OutcomesSubstantial
Risk to Development Outcome
Bank PerformanceSubstantial
Borrower Performance
Government Performance
Implementing Agency

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of women between 30 and 59 years of age with positive HPV screening or cancer who received treatment.Value0.0070.0068.74
    DateMarch 1, 2018February 28, 2023March 31, 2022
    Comment
  • Percentage of people with risk factors that have been diagnosed with Chronic Kidney Disease (CKD) for the first time.Value0.0050.0098.70
    DateMarch 1, 2018February 28, 2023March 31, 2022
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of 9-year-old girls vaccinated against HPV in selected municipalities within the selected regions.Value0.0014000.0017778.00
    DateMarch 1, 2018February 28, 2023March 31, 2022
    Comment
  • Number of people from 30 to 69 years old in the selected regions of the project diagnosed for the first time with Non-Comunicable Disesaes NCD (Dyslipidemias and Diabetes Melliturs DM).Value0.001000.002484.00
    DateMarch 1, 2018February 28, 2023March 31, 2021
    Comment
  • Number of women aged 30 to 59 years old screened for HPV in the selected municipalities within selected regions.Value0.0073508.0082114.00
    DateMarch 1, 2018February 28, 2023March 31, 2022
    Comment